GTx Current Ratio 2006-2018 | GTXI

Historical current ratio values for GTx (GTXI) over the last 10 years.
GTx Annual Current Ratio
2017 5.78
2016 5.27
2015 1.06
2014 1.53
2013 3.32
2012 5.98
2011 13.18
2010 11.38
2009 3.18
2008 4.77
2007 7.88
2006 11.77
2005 12.72
GTx Quarterly Current Ratio
Q1 2018 3.56
Q4 2017 5.78
Q3 2017 6.00
Q2 2017 2.60
Q1 2017 3.94
Q4 2016 5.27
Q3 2016 4.62
Q2 2016 6.19
Q1 2016 8.80
Q4 2015 1.06
Q3 2015 1.10
Q2 2015 0.56
Q1 2015 1.52
Q4 2014 1.53
Q3 2014 5.38
Q2 2014 4.98
Q1 2014 6.44
Q4 2013 3.32
Q3 2013 4.22
Q2 2013 3.93
Q1 2013 5.35
Q4 2012 5.98
Q3 2012 6.22
Q2 2012 8.09
Q1 2012 11.86
Q4 2011 13.18
Q3 2011 16.43
Q2 2011 18.98
Q1 2011 16.04
Q4 2010 11.38
Q3 2010 4.89
Q2 2010 5.55
Q1 2010 4.82
Q4 2009 3.18
Q3 2009 3.13
Q2 2009 3.93
Q1 2009 4.57
Q4 2008 4.77
Q3 2008 5.92
Q2 2008 6.52
Q1 2008 6.55
Q4 2007 7.88
Q3 2007 8.25
Q2 2007 8.30
Q1 2007 9.80
Q4 2006 11.77
Q3 2006 5.92
Q2 2006 8.38
Q1 2006 8.83
Q4 2005 12.72
Q3 2005 4.56
Q2 2005 5.67
Q1 2005 8.88
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.438B $0.000B
GTx, Inc. is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other serious medical conditions. GTx's lead candidate is enobosarm, a selective androgen receptor modulator, or SARM, targeted at the androgen receptor, or AR, in women with advanced breast cancer whose tumors express the androgen receptor and the estrogen receptor, or ER, and women with AR positive triple negative breast cancer. GTx is also evaluating enobosarm for the treatment of other serious medical conditions where building lean body mass is important.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $126.386B 14.51
Gilead Sciences (GILD) United States $97.018B 10.77
Biogen (BIIB) United States $68.636B 14.55
Celgene (CELG) United States $62.789B 12.54
Illumina (ILMN) United States $48.190B 60.37
Vertex Pharmaceuticals (VRTX) United States $44.212B 100.58
Regeneron Pharmaceuticals (REGN) United States $39.102B 21.99
Alexion Pharmaceuticals (ALXN) United States $25.700B 19.32
BioMarin Pharmaceutical (BMRN) United States $18.080B 0.00
Incyte (INCY) United States $14.215B 477.64
Seattle Genetics (SGEN) United States $11.735B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.371B 60.17
Alnylam Pharmaceuticals (ALNY) United States $9.183B 0.00
BeiGene (BGNE) Cayman Islands $8.478B 0.00
QIAGEN (QGEN) Netherlands $8.461B 27.66
Bluebird Bio (BLUE) United States $8.357B 0.00
Sarepta Therapeutics (SRPT) United States $8.353B 0.00
Alkermes (ALKS) Ireland $6.797B 0.00
Bio-Techne Corp (TECH) United States $6.763B 45.45
Exact Sciences (EXAS) United States $5.928B 0.00
Exelixis (EXEL) United States $5.785B 18.84
Galapagos (GLPG) Belgium $5.305B 0.00
Ligand Pharmaceuticals (LGND) United States $5.220B 46.24
Ultragenyx Pharmaceutical (RARE) United States $3.821B 0.00
Immunomedics (IMMU) United States $3.631B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.545B 0.00
Horizon Pharma Public (HZNP) Ireland $3.296B 18.66
Blueprint Medicines (BPMC) United States $3.082B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.022B 0.00
China Biologic Products (CBPO) China $3.016B 19.92
Akcea Therapeutics (AKCA) United States $3.009B 0.00
Myriad Genetics (MYGN) United States $2.960B 35.42
Medicines (MDCO) United States $2.935B 0.00
Array BioPharma (ARRY) United States $2.906B 0.00
Emergent Biosolutions (EBS) United States $2.854B 22.73
Ascendis Pharma (ASND) Denmark $2.797B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.749B 0.00
Amicus Therapeutics (FOLD) United States $2.533B 0.00
Global Blood Therapeutics (GBT) United States $2.496B 0.00
Halozyme Therapeutics (HALO) United States $2.479B 33.04
Spark Therapeutics (ONCE) United States $2.259B 0.00
CRISPR THERAPTC (CRSP) Switzerland $2.239B 0.00
MyoKardia (MYOK) United States $2.234B 0.00
Acceleron Pharma (XLRN) United States $2.188B 0.00
Repligen (RGEN) United States $2.150B 72.18
REGENXBIO (RGNX) United States $2.108B 33.12
Cambrex (CBM) United States $2.044B 16.39
Momenta Pharmaceuticals (MNTA) United States $2.005B 0.00
AnaptysBio (ANAB) United States $1.986B 0.00
Reata Pharmaceuticals (RETA) United States $1.980B 0.00
Mirati Therapeutics (MRTX) United States $1.885B 0.00
G1 THERAPEUTICS (GTHX) United States $1.885B 0.00
Genomic Health (GHDX) United States $1.865B 104.02
Clovis Oncology (CLVS) United States $1.836B 0.00
Arena Pharmaceuticals (ARNA) United States $1.767B 0.00
ACADIA Pharmaceuticals (ACAD) United States $1.724B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.689B 0.00
Rubius Therapeutics (RUBY) United States $1.659B 0.00
Aimmune Therapeutics (AIMT) United States $1.638B 0.00
Atara Biotherapeutics (ATRA) United States $1.628B 0.00
Insmed (INSM) United States $1.618B 0.00
Puma Biotechnology (PBYI) United States $1.614B 0.00
Sangamo Therapeutics (SGMO) United States $1.561B 0.00
Lion Biotechnologies (IOVA) United States $1.558B 0.00
Allakos (ALLK) United States $1.530B 0.00
Denali Therapeutics (DNLI) United States $1.437B 0.00
Myovant Sciences (MYOV) United Kingdom $1.435B 0.00
Innoviva (INVA) United States $1.419B 9.11
Editas Medicine (EDIT) United States $1.386B 0.00
Solid Biosciences (SLDB) United States $1.363B 0.00
WAVE Life Sciences (WVE) Singapore $1.352B 0.00
UniQure (QURE) Netherlands $1.346B 0.00
IMMURON LTD (IMRN) Australia $1.335B 0.00
BIOHAVEN PHARM (BHVN) United States $1.329B 0.00
Acorda Therapeutics (ACOR) United States $1.327B 27.67
Alder BioPharmaceuticals (ALDR) United States $1.279B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.269B 0.00
Coherus BioSciences (CHRS) United States $1.248B 0.00
Audentes Therapeutics (BOLD) United States $1.247B 0.00
Cellectis (CLLS) France $1.171B 0.00
Intellia Therapeutics (NTLA) United States $1.166B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.142B 2180.00
Lexicon Pharmaceuticals (LXRX) United States $1.117B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.105B 0.00
Athenex (ATNX) United States $1.094B 0.00
Intra-Cellular Therapies (ITCI) United States $1.087B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.084B 0.00
Retrophin (RTRX) United States $1.072B 0.00
DBV Technologies (DBVT) France $1.045B 0.00
NeoGenomics (NEO) United States $1.023B 179.00
CytomX Therapeutics (CTMX) United States $1.018B 0.00
Apellis Pharmaceuticals (APLS) United States $0.985B 0.00
AVROBIO (AVRO) United States $0.975B 0.00
Revance Therapeutics (RVNC) United States $0.966B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.964B 0.00
Amarin (AMRN) Ireland $0.865B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.855B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.812B 0.00
Dynavax Technologies (DVAX) United States $0.798B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.796B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.771B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.769B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.769B 0.00
Aptinyx (APTX) United States $0.769B 0.00
Epizyme (EPZM) United States $0.747B 0.00
Heska (HSKA) United States $0.739B 63.60
Kura Oncology (KURA) United States $0.733B 0.00
Cara Therapeutics (CARA) United States $0.726B 0.00
Geron (GERN) United States $0.709B 0.00
InflaRx (IFRX) Germany $0.687B 0.00
UNITY Biotechnology (UBX) $0.664B 0.00
Eidos Therapeutics (EIDX) United States $0.663B 0.00
ANI Pharmaceuticals (ANIP) United States $0.662B 13.11
Viking Therapeutics (VKTX) United States $0.633B 0.00
Abeona Therapeutics (ABEO) United States $0.626B 0.00
Anika Therapeutics (ANIK) United States $0.606B 25.48
Verastem (VSTM) United States $0.590B 0.00
Sorrento Therapeutics (SRNE) United States $0.590B 0.00
AC Immune SA (ACIU) Switzerland $0.580B 0.00
Fate Therapeutics (FATE) United States $0.578B 0.00
Arcus Biosciences (RCUS) United States $0.577B 0.00
UROGEN PHARMA (URGN) Israel $0.573B 0.00
Prothena (PRTA) Ireland $0.568B 0.00
Mesoblast (MESO) Australia $0.558B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.557B 0.00
Replimune (REPL) United States $0.524B 0.00
Senesco Technologies (ELOX) United States $0.499B 0.00
Vericel (VCEL) United States $0.496B 0.00
Arbutus Biopharma (ABUS) Canada $0.490B 0.00
Novavax (NVAX) United States $0.486B 0.00
Five Prime Therapeutics (FPRX) United States $0.484B 0.00
Kindred Biosciences (KIN) United States $0.483B 0.00
ObsEva SA (OBSV) Switzerland $0.473B 0.00
Stemline Therapeutics (STML) United States $0.471B 0.00
Zymeworks (ZYME) Canada $0.447B 0.00
MiMedx (MDXG) United States $0.442B 18.95
BeyondSpring (BYSI) United States $0.433B 0.00
Aduro Biotech (ADRO) United States $0.427B 0.00
Magenta Therapeutics (MGTA) United States $0.425B 0.00
Unum Therapeutics (UMRX) United States $0.424B 0.00
Merus (MRUS) Netherlands $0.424B 0.00
Evelo Biosciences (EVLO) United States $0.420B 0.00
Inovio Pharmaceuticals (INO) United States $0.405B 0.00
Zealand Pharma (ZEAL) Denmark $0.400B 0.00
MediciNova (MNOV) United States $0.388B 0.00
Cytokineticsorporated (CYTK) United States $0.385B 0.00
Sinovac Biotech (SVA) China $0.372B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.366B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.364B 0.00
Vital Therapies (VTL) United States $0.362B 0.00
Syros Pharmaceuticals (SYRS) United States $0.362B 0.00
Albireo Pharma (ALBO) United States $0.357B 0.00
Scholar Rock Holding (SRRK) United States $0.354B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.351B 0.00
RA PHARMCTL INC (RARX) United States $0.337B 0.00
PDL BioPharma (PDLI) United States $0.336B 4.71
Cellular Biomedicine (CBMG) United States $0.321B 0.00
Adverum Biotechnologies (ADVM) United States $0.320B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.319B 0.00
Kezar Life Sciences (KZR) United States $0.316B 0.00
Seres Therapeutics (MCRB) United States $0.315B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.312B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.312B 0.00
BioTime (BTX) United States $0.306B 0.00
Mersana Therapeutics (MRSN) United States $0.294B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.290B 0.00
Selecta Biosciences (SELB) United States $0.289B 0.00
Kala Pharmaceuticals (KALA) United States $0.288B 0.00
Celyad SA (CYAD) Belgium $0.282B 0.00
ResTORbio (TORC) United States $0.282B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.280B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.277B 0.00
Osiris Therapeutics (OSIR) United States $0.274B 0.00
Constellation Pharmaceuticals (CNST) United States $0.273B 0.00
ADMA Biologics Inc (ADMA) United States $0.272B 0.00
Athersys (ATHX) United States $0.270B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.268B 0.00
Celcuity (CELC) United States $0.263B 0.00
Kadmon Holdings (KDMN) United States $0.262B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.259B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.256B 0.00
ChromaDex (CDXC) United States $0.254B 0.00
Idera Pharmaceuticals (IDRA) United States $0.249B 0.00
Axovant Sciences (AXON) United Kingdom $0.247B 0.00
NantKwest (NK) United States $0.244B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.244B 0.00
MeiraGTx Holdings (MGTX) United States $0.240B 0.00
Cohbar (CWBR) United States $0.239B 0.00
Strongbridge Biopharma (SBBP) United States $0.236B 0.00
Allena Pharmaceuticals (ALNA) United States $0.226B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.225B 0.00
Liquidia Technologies (LQDA) United States $0.222B 0.00
Kamada (KMDA) Israel $0.221B 17.19
Clearside Biomedical (CLSD) United States $0.217B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.201B 0.00
Synlogic (SYBX) United States $0.193B 0.00
Agenus (AGEN) United States $0.191B 0.00
Spero Therapeutics (SPRO) United States $0.191B 0.00
Enzo Biochem (ENZ) United States $0.189B 0.00
Palatin Technologies (PTN) United States $0.186B 7.19
Protagonist Therapeutics (PTGX) United States $0.182B 0.00
Menlo Therapeutics (MNLO) United States $0.182B 0.00
Signal Genetics (MGEN) United States $0.179B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) $0.174B 0.00
TOCAGEN INC (TOCA) United States $0.172B 0.00
MannKind (MNKD) United States $0.170B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.168B 0.00
Mustang Bio (MBIO) United States $0.168B 0.00
Krystal Biotech (KRYS) United States $0.167B 0.00
Compugen (CGEN) Israel $0.164B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.164B 0.00
OVID THERAPEUTC (OVID) United States $0.161B 0.00
Cue Biopharma (CUE) United States $0.159B 0.00
BioDelivery Sciences (BDSI) United States $0.156B 0.00
XBiotech (XBIT) United States $0.155B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.155B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.150B 0.00
Pfenex (PFNX) United States $0.148B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.147B 0.00
XOMA (XOMA) United States $0.142B 15.01
Pluristem Therapeutics (PSTI) Israel $0.139B 0.00
Cerecor (CERC) United States $0.137B 16.92
Intec Pharma (NTEC) Israel $0.136B 0.00
BioXcel Therapeutics (BTAI) United States $0.133B 0.00
Provention Bio (PRVB) United States $0.132B 0.00
Motif Bio Plc (MTFB) United States $0.132B 0.00
Monster Digital (INNT) United States $0.130B 0.00
Organovo Holdings (ONVO) United States $0.129B 0.00
VBI Vaccines (VBIV) United States $0.126B 0.00
Aptevo Therapeutics (APVO) United States $0.123B 0.00
Checkpoint Therapeutics (CKPT) United States $0.122B 0.00
Catalyst Biosciences (CBIO) United States $0.121B 0.00
Anavex Life Sciences (AVXL) United States $0.121B 0.00
Trevena (TRVN) United States $0.119B 0.00
Cidara Therapeutics (CDTX) United States $0.118B 0.00
Cocrystal Pharma (COCP) United States $0.117B 0.00
PSivida (EYPT) United States $0.111B 0.00
Fortress Biotech (FBIO) United States $0.110B 0.00
Tapimmune (TPIV) United States $0.106B 0.00
Leap Therapeutics (LPTX) United States $0.103B 0.00
NewLink Genetics (NLNK) United States $0.103B 0.00
Orgenesis (ORGS) United States $0.101B 0.00
Aptose Biosciences (APTO) Canada $0.098B 0.00
Eleven Biotherapeutics (SESN) United States $0.093B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.092B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.090B 0.00
ScPharmaceuticals (SCPH) United States $0.087B 0.00
Asterias Biotherapeutics (AST) United States $0.086B 0.00
Alcobra (ARCT) Israel $0.086B 0.00
Ophthotech (OPHT) United States $0.085B 0.55
Proteostasis Therapeutics (PTI) United States $0.083B 0.00
OncoSec Medical (ONCS) United States $0.083B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.077B 0.00
Histogenics (HSGX) United States $0.076B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.076B 0.00
Sophiris Bio (SPHS) United States $0.075B 0.00
Advaxis (ADXS) United States $0.075B 0.00
Applied Genetic Technologies (AGTC) United States $0.074B 0.00
Oncolytics Biotech (ONCY) Canada $0.074B 0.00
Protalix BioTherapeutics (PLX) Israel $0.071B 0.00
Celldex Therapeutics (CLDX) United States $0.069B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.068B 0.00
Evogene (EVGN) Israel $0.068B 0.00
VIVUS (VVUS) United States $0.067B 0.00
Prima BioMed (IMMP) Australia $0.067B 0.00
Alimera Sciences (ALIM) United States $0.067B 0.00
Axsome Therapeutics (AXSM) United States $0.060B 0.00
TRACON Pharmaceuticals (TCON) United States $0.060B 0.00
Novelion Therapeutics (NVLN) Canada $0.059B 0.00
Entera Bio (ENTX) Israel $0.058B 0.00
Neothetics (EVFM) United States $0.057B 0.00
Eyenovia (EYEN) United States $0.055B 0.00
VolitionRX (VNRX) Singapore $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.050B 0.00
Caladrius Biosciences (CLBS) United States $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.046B 0.00
Zosano Pharma (ZSAN) United States $0.046B 0.00
CorMedix Inc (CRMD) United States $0.046B 0.00
Celsion (CLSN) United States $0.045B 0.00
Chiasma (CHMA) United States $0.043B 0.00
Moleculin Biotech (MBRX) United States $0.043B 0.00
GENPREX INC (GNPX) United States $0.042B 0.00
AZURRX BIOPHARM (AZRX) United States $0.040B 0.00
Proteon Therapeutics (PRTO) United States $0.040B 0.00
VTv Therapeutics (VTVT) United States $0.039B 0.00
Bellerophon Therapeutics (BLPH) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
CytRx (CYTR) United States $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.032B 0.00
Arsanis (ASNS) United States $0.032B 0.00
Aileron Therapeutics (ALRN) United States $0.031B 0.00
BioPharmX (BPMX) United States $0.031B 0.00
Benitec Biopharma (BNTC) Australia $0.031B 0.00
AEterna Zentaris (AEZS) United States $0.031B 62.67
OvaScience (OVAS) United States $0.029B 0.00
VistaGen Therapeutics (VTGN) United States $0.029B 0.00
Vical (VICL) United States $0.028B 0.00
Edge Therapeutics (EDGE) United States $0.028B 0.00
Oncobiologics (ONS) United States $0.028B 0.00
Adial Pharmaceuticals (ADIL) United States $0.025B 0.00
Cellect Biotechnology (APOP) Israel $0.024B 0.00
Cel-Sci (CVM) United States $0.023B 0.00
Soligenix (SNGX) United States $0.023B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
RestorGenex (DFFN) United States $0.021B 0.00
Gemphire Therapeutics (GEMP) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
AmpliPhi Biosciences (APHB) United States $0.019B 0.00
ATyr Pharma (LIFE) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.019B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Prana Biotechnology (PRAN) Australia $0.019B 0.00
Neuralstem (CUR) United States $0.017B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Hemispherx BioPharma (HEB) United States $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.013B 6.57
Cerulean Pharma (DARE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Synthetic Biologics (SYN) United States $0.010B 0.00
Flex Pharma (FLKS) United States $0.010B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
IBio (IBIO) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
Galena Biopharma (SLS) United States $0.007B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
Oragenics (OGEN) United States $0.003B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.002B 0.00
Aytu Bioscience (AYTU) United States $0.001B 0.00